BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Drug Discovery

Nuance Pharma Secures NMPA Clearance For Pivotal Actair® Allergy Trial In China

NMPA Approval Marks Key Milestone in Advancing House Dust Mite Allergy Immunotherapy to Chinese Patients Nuance Pharma announced that the National Medical...

May 25, 2026 | News

AbbVie Receives Positive CHMP Opinion For MAVIRET In Acute Hepatitis C Treatment

The positive opinion is supported by data from the Phase 3 M20-350 study evaluating the safety and efficacy of MAVIRET® in a...

May 25, 2026 | News

Lupin Limited Enters China Market With Approval For Paediatric Oseltamivir Oral Suspension

Global pharmaceutical company Lupin Limited announced that China's National Medical Products Administration has approved the shortened marketing authorizat...

May 25, 2026 | News

FUJIFILM Cellular Dynamics Opens New U.S. iPSC Manufacturing Hub To Expand Cell Therapy And Drug Discovery Capabilities

Site will serve as company’s new headquarters and expands capacity and capabilities for induced pluripotent stem cell development...

May 21, 2026 | News

Thermo Fisher Scientific Expands PPD Laboratory Services Network With New Bioanalytical Facility In Sweden

The state-of-the-art facility enhances support for complex modalities across all phases of drug development Key facts Thermo Fisher opens new bioa...

May 19, 2026 | News

NinaMED Pty Ltd Launches With US$13.75 Million Financing To Advance Non Invasive OAB Therapy

US$13.75M financing completed to accelerate clinical pathway and global commercialisation Establishment of NinaMED Pty Ltd, a new Australian medtech com...

May 18, 2026 | News

FDA Approves First All Oral INQOVI Plus Venetoclax Regimen For Newly Diagnosed AML Patients Ineligible For Intensive Chemotherapy

Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd., announced that the U.S. Food and Drug Administration (FDA) has approved INQOVI (decitabine and ced...

May 15, 2026 | News

Suzhou Ribo Life Science And Insilico Medicine Forge Strategic Alliance To Accelerate AI Powered siRNA Drug Development

Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK) announced that the Company has entered into a strategic collaboration agreement with Insilico Me...

May 14, 2026 | News

Isomorphic Labs Raises $2.1 Billion To Scale AI Driven Drug Discovery Platform

Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline...

May 14, 2026 | News

GenScript Biotech Launches TurboCHO Protein Expression Kit To Accelerate Antibody Discovery Workflows

New kit offers researchers and development teams a meaningful advance in expression speed and output GenScript Biotech Corporation announced the laun...

May 14, 2026 | News

Benchling Launches Antibody R&D Platform To Accelerate Biologics Discovery And Development

Benchling announced Benchling Biologics, an end-to-end platform for antibody R&D, today at the PEGS Boston Summit. Scientists can configure a...

May 13, 2026 | News

Cellenkos Advances CK0802 Into Phase 1b 2a Trial Following FDA Clearance For Steroid Refractory GVHD

Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf Treg therapy, in patients with s...

May 06, 2026 | News

Quantum Breakthrough Enables Largest Ever Protein Simulations Advancing Drug Discovery Potential

Scientists at Cleveland Clinic, RIKEN, and IBM (NYSE: IBM) have used IBM quantum computers and two of the world's most powerful supercomputers to simu...

May 06, 2026 | News

UltraGreen.ai Secures Singapore Approval For Verdye Strengthening Southeast Asia Surgical Innovation Strategy

Approval in a strategic healthcare hub strengthens regional growth strategy and supports clinical adoption of fluorescence-guided surgery Ultr...

May 06, 2026 | News

Stay Connected